Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
07/30/14 Baxter (BAX) HyQvia for Primary Immunodeficiencies Subscribers Only Subscribers Only     Subscribers Only
07/30/14 Sarepta (SRPT) Eteplirsen for Muscular Dystrophy Subscribers Only Subscribers Only     Subscribers Only
07/30/14 Actavis (ACT) Tudorza-formoterol for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only     Subscribers Only
07/30/14 Regeneron (REGN) Alirocumab for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only     Subscribers Only
07/30/14 Incyte (INCY) INCB24360 for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/31/14 Subscribers Only Subscribers Only Trial Announcement - Initiation
07/31/14 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Results
07/31/14 Subscribers Only Subscribers Only Regulatory - Approval Decision (Japan)
07/31/14 Subscribers Only Subscribers Only Partnership - New
07/31/14 Subscribers Only Subscribers Only Trial Announcement - Trial Completion